Parents of Children with Sickle Cell Disease Are Interested in Preimplantation Genetic Testing

Monica Attia1, Shawn Kripalani1, Isha Darbari2

  • 1The George Washington University School of Medicine and Health Sciences, Washington, DC.

Insights

Most parents of children with sickle cell disease (SCD) are unaware of preimplantation genetic testing (PGT). Education significantly increased awareness and interest in PGT as a reproductive option.

Area of Science:

  • Genetics
  • Reproductive Medicine
  • Hematology

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder affecting millions worldwide.
  • Preimplantation genetic testing (PGT) offers a way to screen embryos for genetic conditions before implantation.
  • Awareness of PGT for SCD among affected families is not well understood.

Purpose of the Study:

  • To assess parental awareness and attitudes towards PGT for SCD.
  • To evaluate the impact of educational interventions on PGT knowledge and perception.

Main Methods:

  • A cohort of parents with children diagnosed with SCD received an educational handbook on PGT.
  • Anonymous surveys were administered post-clinic visit to gauge awareness and attitudes.
  • Data analysis included descriptive statistics of survey responses.

Main Results:

  • Only 24% of parents were previously aware of PGT for SCD.
  • Post-education, 97% deemed PGT information important for parents of children with SCD.
  • 91% of parents interested in future pregnancies would consider PGT if insurance covered it.

Conclusions:

  • There is a significant lack of awareness regarding PGT for SCD among parents.
  • Clinic-based education effectively highlights the value of PGT information.
  • Healthcare providers should proactively discuss PGT as a reproductive option for families affected by SCD.
Abstract